This paper is in the following e-collection/theme issue:

Pharmacovigilance (138) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (159) Safety and Error Prevention in Health (206) Infoveillance, Infodemiology, Digital Disease Surveillance, Infodemic Management (1050) Infodemiology and Infoveillance (1369) Mass Media/Social Media Communication and Campaigns (466)

Published on in Vol 8, No 1 (2022): January

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/33311, first published .
Comparison of Online Patient Reviews and National Pharmacovigilance Data for Tramadol-Related Adverse Events: Comparative Observational Study

Comparison of Online Patient Reviews and National Pharmacovigilance Data for Tramadol-Related Adverse Events: Comparative Observational Study

Comparison of Online Patient Reviews and National Pharmacovigilance Data for Tramadol-Related Adverse Events: Comparative Observational Study

Authors of this article:

Susan Park1 Author Orcid Image ;   So Hyun Choi2 Author Orcid Image ;   Yun-Kyoung Song3 Author Orcid Image ;   Jin-Won Kwon4 Author Orcid Image
Article Authors Cited by (6) Tweetations (7) Metrics

Journals

  1. Kang D, Kim S, Kim H, Lee M, Kong S, Chang Y, Sim S, Kim Y, Cho J. Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of Cancers During Chemoradiation Therapy: Real-World Study. JMIR Public Health and Surveillance 2023;9:e44105 View
  2. Sarker J, Carkovic E, Ptaszek K, Lee T. Antiviral influenza treatments and hemorrhage‐related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2024;44(5):383 View
  3. Golder S, O'Connor K, Wang Y, Klein A, Gonzalez Hernandez G. The Value of Social Media Analysis for Adverse Events Detection and Pharmacovigilance: Scoping Review. JMIR Public Health and Surveillance 2024;10:e59167 View
  4. Nezhurina E, Milchakov K, Abramova A. Social Media as a Source of Information for the Detection of Adverse Drug Reactions in Post-Marketing Surveillance: A Review. Safety and Risk of Pharmacotherapy 2024 View
  5. Zhang J, Wang X, Zhou Y. Comparative analysis of semaglutide induced adverse reactions: Insights from FAERS database and social media reviews with a focus on oral vs subcutaneous administration. Frontiers in Pharmacology 2024;15 View
  6. Martinez de la Torre A, Clausen A, Burden A, Weiler S. Fracture-Related Safety Reporting of JAK Inhibitors: An Analysis from the WHO Global VigiBase. Drug Safety 2024 View